Neutralizing anti-influenza binding molecules and uses thereof Grant US-11926657-B2 United States of America 12 Mar 2024
Influenza virus hemagglutinin proteins and uses thereof Grant US-11865173-B2 United States of America 09 Jan 2024
Composition and methods based on neutralizing antibodies delivered intranasally for… Grant US-11827693-B2 United States of America 28 Nov 2023
Adeno-associated virus (AAV) clade f vector and uses therefor Grant US-11827906-B2 United States of America 28 Nov 2023
Neutralizing anti-influenza b antibodies and uses thereof Grant US-11787853-B2 United States of America 17 Oct 2023
Hemagglutinin-specific antibodies and uses thereof Grant US-11566064-B2 United States of America 31 Jan 2023
AAV-mediated expression of anti-influenza antibodies and methods of use thereof Grant US-11535665-B2 United States of America 27 Dec 2022
Neutralizing anti-influenza binding molecules and uses thereof Grant US-11524993-B2 United States of America 13 Dec 2022
MANIPULATION OF IMMUNOGLOBULIN GENE DIVERSITY AND MULTI-ANTIBODY THERAPEUTICS Application EP-4091442-A1 European Patent Office 23 Nov 2022
Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use… Grant US-11505597-B2 United States of America 22 Nov 2022
Human antibodies to influenza hemagglutinin Grant US-11453714-B2 United States of America 27 Sep 2022
IMMUNOGENETIC RESTRICTION ON ELICITATION OF ANTIBODIES Application EP-4043489-A1 European Patent Office 17 Aug 2022
ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION Application WO-2022125517-A1 World Intellectual Property Organisation (WIPO) 16 Jun 2022
Methods for identifying coronavirus cross-reacting antibodies Grant NL-2026043-B1 Netherlands 15 Mar 2022
Influenza virus hemagglutinin proteins and uses thereof Grant US-11266734-B2 United States of America 08 Mar 2022
Anti-influenza B virus neuraminidase antibodies and uses thereof Grant US-11254733-B2 United States of America 22 Feb 2022
Antibodies useful in passive influenza immunization, and compositions, combinations and… Grant US-11246928-B2 United States of America 15 Feb 2022
METHODS FOR IDENTIFYING CORONAVIRUS CROSS-REACTING ANTIBODIES Application WO-2022010353-A1 World Intellectual Property Organisation (WIPO) 13 Jan 2022
Neutralizing anti-influenza B antibodies and uses thereof Grant US-11174304-B2 United States of America 16 Nov 2021
COMPOSITIONS AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION Application WO-2021041989-A1 World Intellectual Property Organisation (WIPO) 04 Mar 2021
Neutralizing anti-influenza binding molecules and uses thereof Grant US-10882897-B2 United States of America 05 Jan 2021
Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use… Grant US-10851155-B2 United States of America 01 Dec 2020
ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION Application WO-2020221908-A1 World Intellectual Property Organisation (WIPO) 05 Nov 2020
ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION Application WO-2020221450-A1 World Intellectual Property Organisation (WIPO) 05 Nov 2020
Neutralizing anti-influenza A virus antibodies and uses thereof Grant US-10815294-B2 United States of America 27 Oct 2020
Human antibodies to influenza hemagglutinin Grant US-10689436-B2 United States of America 23 Jun 2020
Antibodies useful in passive influenza immunization Grant US-10654915-B2 United States of America 19 May 2020
Antibodies useful in passive influenza immunization, and compositions, combinations and… Grant US-10639370-B2 United States of America 05 May 2020
Antibodies against influenza virus hemagglutinin and uses thereof Grant US-10544207-B2 United States of America 28 Jan 2020
Neutralizing anti-influenza B antibodies and uses thereof Grant US-10519221-B2 United States of America 31 Dec 2019
Neutralizing anti-influenza A antibodies and uses thereof Grant US-10494419-B2 United States of America 03 Dec 2019
Neutralizing anti-influenza binding molecules and uses thereof Grant US-10442854-B2 United States of America 15 Oct 2019
Human antibodies to influenza hemagglutinin Grant US-10392432-B2 United States of America 27 Aug 2019
Methods and composition for neutralization of influenza Grant US-10357563-B2 United States of America 23 Jul 2019
Recombinant viral vectors and methods for inducing a heterosubtypic immune response to… Grant US-10329583-B2 United States of America 25 Jun 2019
Neutralizing anti-influenza B antibodies and uses thereof Grant US-10294292-B2 United States of America 21 May 2019
CROSS-PROTECTIVE PROTECTION AGAINST INFLUENZA VIRAL INFECTION Application EP-3450454-A1 European Patent Office 06 Mar 2019
Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use… Grant US-10131704-B2 United States of America 20 Nov 2018
INFLUENZA VACCINES BASED ON AAV VECTORS Application WO-2018160573-A1 World Intellectual Property Organisation (WIPO) 07 Sep 2018
ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION Grant EP-2582721-B1 European Patent Office 22 Aug 2018
HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA VIRUS H3N2 AND USES THEREOF Application EA-029939-B1 Eurasian Patent Organisation 29 Jun 2018
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Application US-10005831-B2 United States of America 26 Jun 2018
Antibodies against influenza virus hemagglutinin and uses thereof Grant US-9908930-B2 United States of America 06 Mar 2018
Binding molecule having influenza A virus-neutralizing activity produced from human B cell Grant US-9856312-B2 United States of America 02 Jan 2018
ANTIBODY THAT BINDS TO INFLUENZA B VIRUSES AND USE THEREOF Application EA-028433-B1 Eurasian Patent Organisation 30 Nov 2017
Composition and methods based on neutralizing antibodies delivered intranasally for… Grant US-9718875-B2 United States of America 01 Aug 2017
Vaccines for use in the prophylaxis and treatment of influenza virus disease Grant US-9701723-B2 United States of America 11 Jul 2017
HUMAN MONOCLONAL ANTIBODIES DERIVED FROM HUMAN B CELLS AND HAVING NEUTRALIZING ACTIVITY… Application EP-3098236-A1 European Patent Office 30 Nov 2016
Binding molecule having influenza A virus-neutralizing activity produced from human B cell Grant US-9475861-B2 United States of America 25 Oct 2016
Recombinant viral vectors and methods for inducing a heterosubtypic immune response to… Grant US-9463237-B2 United States of America 11 Oct 2016
Recombinant antibodies against H1N1 influenza Grant US-9458226-B2 United States of America 04 Oct 2016
IMMUNOGENETIC RESTRICTION ON ELICITATION OF ANTIBODIES Application WO-2015143194-A3 World Intellectual Property Organisation (WIPO) 12 Nov 2015
Monoclonal antibodies against influenza virus generated by cyclical administration and… Grant US-9175069-B2 United States of America 03 Nov 2015
Human monoclonal antibodies derived from human B cells and having neutralizing activity… Application EP-2860190-A3 European Patent Office 15 Jul 2015
Influenza virus vaccines and uses thereof Application US-9051359-B2 United States of America 09 Jun 2015
BINDING MOLECULE HAVING INFLUENZA A VIRUS-NEUTRALIZING ACTIVITY PRODUCED FROM HUMAN B CELL Application EP-2762491-A4 European Patent Office 20 May 2015
ANTIBODY HAVING BROAD NEUTRALIZING ACTIVITY IN GROUP 1 INFLUENZA A VIRUS Application WO-2015068781-A1 World Intellectual Property Organisation (WIPO) 14 May 2015
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Grant US-9011848-B2 United States of America 21 Apr 2015
Compositions and methods for production of immunoglobulins Grant US-8962278-B2 United States of America 24 Feb 2015
Influenza hemagglutinin antibodies, compositions and related methods Grant US-8784819-B2 United States of America 22 Jul 2014
Trypanosoma antigens, vaccine compositions, and related methods Grant US-8778348-B2 United States of America 15 Jul 2014
Humanized neuraminidase antibody and methods of use thereof Grant US-8734803-B2 United States of America 27 May 2014
Passive immunisation against influenza, in particular H5N1 Application EP-2712626-A1 European Patent Office 02 Apr 2014
Monoclonal antibodies against influenza virus generated by cyclical administration and… Grant US-8673314-B2 United States of America 18 Mar 2014
Recombinant carrier molecule for expression, delivery and purification of target… Grant US-8591909-B2 United States of America 26 Nov 2013
HUMAN BINDING MOLECULES CAPABLE OF BINDING TO AND NEUTRALIZING INFLUENZA B VIRUSES AND… Application WO-2013132007-A1 World Intellectual Property Organisation (WIPO) 12 Sep 2013
Human monoclonal antibodies derived from human B cells and having neutralizing activity… Grant AU-2011225044-B2 Australia 22 Aug 2013
INFLUENZA A VIRUS SPECIFIC ANTIBODIES Application WO-2013081463-A2 World Intellectual Property Organisation (WIPO) 06 Jun 2013
MANIPULATION OF IMMUNOGLOBULIN GENE DIVERSITY AND MULTI-ANTIBODY THERAPEUTICS Application WO-2013041846-A2 World Intellectual Property Organisation (WIPO) 28 Mar 2013
Yersinia pestis antigens, vaccine compositions, and related methods Grant US-8404252-B2 United States of America 26 Mar 2013
AN ANTIGENIC PEPTIDE DERIVED FROM INFLUENZA VIRUS AND A METHOD FOR SELECTING ANTI-INFLUENZA… Application EP-2443138-A4 European Patent Office 28 Nov 2012
HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA VIRUS H5N1 AND USES THEREOF Application US-20120276115-A1 United States of America 01 Nov 2012
Bacillus anthracis antigens, vaccine compositions, and related methods Grant US-8277816-B2 United States of America 02 Oct 2012
RECOMBINANT VIRAL VECTORS AND METHODS FOR INDUCING A HETEROSUBTYPIC IMMUNE RESPONSE TO… Application WO-2012106231-A2 World Intellectual Property Organisation (WIPO) 09 Aug 2012
INFLUENZA HEMAGGLUTININ ANTIBODIES, COMPOSITIONS, AND RELATED METHODS Application EP-2483307-A1 European Patent Office 08 Aug 2012
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Application EP-2450376-A3 European Patent Office 01 Aug 2012
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Application EP-2455399-A3 European Patent Office 30 May 2012
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Application EP-2455398-A3 European Patent Office 30 May 2012
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Application EP-2450378-A1 European Patent Office 09 May 2012
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Application EP-2450377-A1 European Patent Office 09 May 2012
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof Application EP-2450379-A1 European Patent Office 09 May 2012
Recombinant carrier molecule for expression, delivery and purification of target… Grant US-8173408-B2 United States of America 08 May 2012
AN ANTIGENIC PEPTIDE DERIVED FROM INFLUENZA VIRUS AND A METHOD FOR SELECTING ANTI-INFLUENZA… Application EP-2443138-A1 European Patent Office 25 Apr 2012